Developer docs
API playgroundTry for free, no card

Search company profiles

Surfacide

Full company profile

uuid000a4qy

Namestring
Surfacide
Legal namestring
Surfacide, LLC.
Websiteurl
surfacide.com
Company typeenum
Private
Founded yearint
2010
Descriptiontext

Surfacide, LLC., founded in 2010 and headquartered in Waukesha, Wisconsin, manufactures UV-C microbial reduction systems for healthcare and commercial infection prevention. Its core technology is a patented triple-emitter UV-C architecture operating at approximately 254nm wavelength that applies inverse square law physics — deploying multiple light towers to shorten the distance from UV-C source to target surfaces, thereby reducing shadowing and cycle time without requiring repositioning. The product portfolio includes the FDA-authorized Helios+ UV-C System (Class II Medical Device), the first-generation Helios UV-C System (supporting up to five towers), PathTrac clinical decision support software for operating-room infection protocol monitoring, and SURFcare, a white-glove service program bundling dedicated account management, equipment maintenance, firmware updates, and cloud-based analytics reporting.

The company generates revenue through a combination of capital equipment sales (Helios+ and Helios systems, configurable with 1–3 or 1–5 emitters respectively) and recurring service revenue from the SURFcare program and PathTrac software subscriptions. Go-to-market combines direct enterprise field sales (with "Book a Demo" CTAs and virtual demos) targeting acute care hospitals, non-acute care facilities, government VA hospitals, dental offices, and non-healthcare commercial venues; channel partnerships with GPOs Premier and Vizient and credibility partners Leapfrog and KLAS; Foodbuy for commercial procurement; BreeWorld as an SDVOSB distributor for federal/DOD contracts; and a network of regional distributors covering 20+ countries across North America, Latin America, Europe, the Middle East, Africa, and Oceania. The company reports deployment across more than 1,000 facilities worldwide, holds ISO 13485:2016 MDSAP certification and BS 8626:2022 compliance, and operates with 11–50 employees under CEO Gunner Lyslo.

Short descriptiontext

Surfacide designs and manufactures patented triple-emitter UV-C microbial reduction systems and infection-prevention software for healthcare facilities, government institutions, and commercial venues across 20+ countries.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersWaukesha, United States
HQ citystring
Waukesha
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
UV-C disinfection systems, infection prevention technology, healthcare disinfection equipment, microbial reduction devices, UV-C germicidal technology
Industry1 code
PRIMARYHLAHANAD
Disinfection & Surface Decontamination (Wipes, Sprays, Fogging, UV Robots)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Sterilization, Infection Prevention & Medical Disposables
NAICS code1 code
  • Surgical and Medical Instrument Manufacturing339112
SIC code2 codes
  • Surgical & Medical Instruments & Apparatus3841
  • Industrial & Commercial Fans & Blowers & Air Purifing Equip3564
Product category
Healthcare Disinfection Equipment
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model4 records
1UV-C Hardware Systems
TypeHardware Sales
Description

Sale of UV-C microbial reduction systems (Helios+, Helios) with multiple emitter configurations. Systems include robots/emitters, safety sensors, tablets, and cloud connectivity.

surfacide.com
2SURFcare Service Program
TypeSubscription Recurring
Description

Premium customer service program offering dedicated account manager, equipment maintenance, software/firmware updates, cloud database reporting, and equipment replacement. First year included with purchase.

surfacide.com
3Advanced Analytics Dashboard
TypeSubscription Recurring
Description

Customizable dashboard with widgets for data analysis, real-time data access, and scheduled reports. Part of SURFcare program.

surfacide.com
4PathTrac Software
TypeSubscription Recurring
Description

Clinical decision support software for operating room infection prevention protocols. Includes features for pathogen tracking, transmission mapping, and process optimization.

surfacide.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Supply Chain, Personnel, Technology or R&D, Marketing or Sales, Operations
Pricing details2 tiers
1Helios+ UV-C System with 3 emitters at competitive price point
ModelUnit PricingBilling cadenceMulti-year contract
Notes

Cost advantage with three UV-C emitters included at similar price to single-emitter systems. For added flexibility, emitters can be utilized with 1 to 3 robots.

surfacide.com
2SURFcare Premium Service Program
ModelSubscriptionBilling cadenceAnnual
Notes

First year of SURFcare included with every purchase at no additional cost. Program includes dedicated account manager, equipment management, software updates, and cloud reporting.

surfacide.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 4 records shown
1Helios+ UV-C System
Description

FDA-authorized Class II Medical Device UV-C system featuring three light-emitting towers for whole room microbial reduction.

surfacide.com
+3 more records
Core offering1 text field

Surfacide designs, engineers, and manufactures patented triple-emitter UV-C microbial reduction systems (Helios+ and Helios) that deliver whole-room disinfection of hard, non-critical medical device surfaces without repositioning. The systems use 253.7nm wavelength UV-C light to disrupt DNA/RNA of bacteria, some fungi, and lipid viruses, and are complemented by the PathTrac clinical decision support software and the SURFcare customer service program.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Multiple emitter configurations eliminate need for repositioning, resulting in short cycle times and increased staff productivity
+2 more records
Product overview1 text field

Surfacide provides a portfolio of UV-C microbial reduction technology products and infection prevention software. The core offering is the Helios+ UV-C System (FDA-authorized Class II medical device) featuring a patented triple-emitter system for whole-room disinfection with no repositioning required. The earlier-generation Helios UV-C System offers similar technology with 1-5 tower configurability. PathTrac clinical decision support software complements the hardware by providing operating room infection monitoring through case pair modeling, transmission mapping, and bacterial strain identification. The SURFcare program delivers ongoing customer support, equipment management, and analytics services.

Product and service4 records
1Helios+ UV-C System
CategoryUV-C Disinfection Hardware
Description

FDA-authorized Class II medical device using a patented triple-emitter UV-C system operating at 253.7nm wavelength. Delivers whole-room microbial reduction on hard surfaces without repositioning through three simultaneously operating towers capable of 360-degree rotation, with configurable 1-3 tower deployments, safety sensors, and automatic cloud-based cycle data reporting. Designed for healthcare facilities including operating rooms, patient rooms, and clinical settings.

2Helios UV-C System
CategoryUV-C Disinfection Hardware
Description

First-generation UV-C microbial reduction system with triple-emitter technology and configurable 1-5 tower configurations. Features 360-degree rotating light towers, motion sensors for safety, targeted area disinfection capabilities, and cloud-connected cycle data reporting. Sold to healthcare and commercial customers as Surfacide's original UV-C platform.

3PathTrac
CategoryClinical Decision Support Software
Description

Clinical decision support software for operating room infection prevention that identifies breakdowns in protocols through case pair modeling, transmission mapping, reservoir monitoring, and bacterial strain identification (MRSA, ESKAPE pathogens). Monitors the four pillars of infection control: hand hygiene, environmental cleaning, vascular care, and patient decolonization. Sold to healthcare facilities, particularly hospitals with operating room programs.

4SURFcare Program
CategoryCustomer Service Program
Description

White-glove concierge customer service program providing a dedicated account manager, equipment maintenance and replacement, software and firmware updates, and cloud database analytics with customizable reporting dashboards. First year included with every UV-C system purchase at no additional cost; subscription renewals thereafter. Targets Surfacide UV-C hardware customers.

Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership16 partners
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Foodbuy enhances Surfacide's market reach and assists in procurement processes. As a group purchasing partner, Foodbuy provides access to their member network for commercial customers seeking UV-C disinfection solutions.

2BreeWorld
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Designated Service-Disable Veteran-Owned Small Business (SDVOSB) distributor with more than 30 years DOD and Federal experience in healthcare industry. Provides access to government and federal healthcare contracts.

surfacide.com
Strategic tierFlagshipTypeGTM or Marketing Partner
Description

Leapfrog serves as the foremost voice for business leaders advancing excellence in healthcare by setting standards and publishing ratings of hospitals and ASCs on quality of care. Partnership validates Surfacide's positioning in healthcare infection prevention.

Strategic tierCoreTypeGTM or Marketing Partner
Description

Data-driven company on a mission to improve healthcare by enabling provider and payer voices to be heard. KLAS research directly reflects voice of healthcare professionals, providing market validation.

Strategic tierFlagshipTypeChannel Partner/ Reseller/ Distributor
Description

Premier connects Surfacide with acute, non-acute, and alternate care site member communities. Group purchasing organization providing access to thousands of healthcare facilities.

Strategic tierFlagshipTypeChannel Partner/ Reseller/ Distributor
Description

Vizient offers greater access of Surfacide UV-C to more healthcare facilities in the US. Leading healthcare performance improvement company providing group purchasing services.

7Dovonixc Global
Strategic tierRegionalTypeChannel Partner/ Reseller/ Distributor
Description

Distributor for Africa/Nigeria region. Contact: +234 708 249 6134, info@dovonixcglobal.com

surfacide.com
Strategic tierRegionalTypeChannel Partner/ Reseller/ Distributor
Description

Distributor for Australia/New Zealand region. Contact: +61 2 8459 7588, sales@wilhelm.com.au

Strategic tierRegionalTypeChannel Partner/ Reseller/ Distributor
Description

Vice President of Sales for Central & South America region. Contact: +305-458-4971

10Alkamedica
Strategic tierRegionalTypeChannel Partner/ Reseller/ Distributor
Description

Distributor for Colombia/Costa Rica. CEO: Dra. Adiela Maria Cortes Cortes. Contact: +57-316-522-4029, acortes@alkamedica.com, www.alkamedica.com

surfacide.com
Strategic tierRegionalTypeChannel Partner/ Reseller/ Distributor
Description

Distributor for Mexico. Contact: Ian Rios, ventas@surfacidemexico.com, www.surfacidemexico.com

Strategic tierRegionalTypeChannel Partner/ Reseller/ Distributor
Description

Distributor for Switzerland. Contact: Rene Meyer, +41 56 664 16 01, r.meyer@uvc-technik.ch, www.uvc-technik.ch

13Surfacide UK
Strategic tierRegionalTypeChannel Partner/ Reseller/ Distributor
Description

Distributor for United Kingdom. UK Projects Manager: Jacob Veenhuis. Contact: jacobv@surfacidemfg.com

surfacide.com
14Dr. Sultan Alkhereiji / Alrowad
Strategic tierRegionalTypeChannel Partner/ Reseller/ Distributor
Description

Distributor for Kingdom of Saudi Arabia. Address: WAHA DISTRICT, UTHMAN IBN AFFAN Rd. Contact: sultan@alrowad-ksa.com, Phone: +966 535631313, Office: +966 11 400 5640

surfacide.com
15Surfacide Medikal Teknolojileri Limited
Strategic tierRegionalTypeChannel Partner/ Reseller/ Distributor
Description

Distributor for Turkey. Global Business Consultant: Kasim Okcu. Contact: 90-505-502-3411

surfacide.com
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Industry association membership demonstrating commitment to UV technology standards and advancement. Part of industry ecosystem for infection prevention.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Xenex sells the LightStrike pulsed-xenon UV robot for whole-room microbial reduction in hospitals, directly competing with Surfacide's Helios/Helios+ on the same no-repositioning room disinfection use case and selling into the same acute-care infection prevention buyer.

TypeDirect peer
Description

Tru-D markets a UV-C disinfection robot for healthcare terminal cleaning and HAI reduction, targeting the same hospital EVS and infection prevention decision makers as Surfacide and competing on dose delivery and single-cycle efficacy claims.

TypeBroad incumbent
Description

Clorox Healthcare is a major manufacturer of manual disinfectants, wipes, and surface cleaning chemistries used in hospitals, sitting alongside (and sometimes against) UV-C adjuncts like Surfacide's Helios+ in healthcare facility disinfection protocols.

TypeBroad incumbent
Description

PDI Healthcare supplies disinfectants, wipes, and infection prevention products to acute and non-acute care settings, making it a broad incumbent whose portfolio complements or competes with Surfacide's UV-C hardware for the same hospital cleaning budget.

TypeBroad incumbent
Description

3M's Health Care division spans surgical, infection prevention, and patient monitoring products and addresses the same hospital disinfection and environment-of-care spend as Surfacide, though as part of a much broader medtech portfolio.

TypeBroad incumbent
Description

Ecolab is a global leader in water, hygiene, and infection prevention solutions, serving hospitals and hospitality with cleaning chemistries and increasingly digital compliance programs that overlap with Surfacide's healthcare and commercial UV disinfection footprint.

TypeEmerging player
Description

AquiSense designs UV-C LED disinfection modules primarily for water and air treatment. It is an emerging player whose UV-C core technology overlaps with Surfacide's, though its focus is on point-of-use water/air systems rather than whole-room healthcare disinfection.

TypeDirect peer
Description

American Ultraviolet manufactures UV germicidal fixtures and mobile UV-C disinfection units used in healthcare and commercial settings, making it a long-standing peer in the UV-C room disinfection category where Surfacide competes.

TypeBroad incumbent
Description

Halma is a diversified group of safety and health technology companies with subsidiaries in UV-C disinfection and infection prevention, making it a broad incumbent in the healthcare and life-safety sensing and disinfection space where Surfacide operates.

TypeEmerging player
Description

UV Smart offers UV-C disinfection devices for medical instruments and surfaces in clinical settings, an emerging player whose UV-C healthcare disinfection focus creates partial overlap with Surfacide's surface and equipment decontamination offering.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers11 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature8 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Surfacide

Healthcare Disinfection Equipmentsurfacide.com

Surfacide designs and manufactures patented triple-emitter UV-C microbial reduction systems and infection-prevention software for healthcare facilities, government institutions, and commercial venues across 20+ countries.

What Surfacide does

Surfacide, LLC., founded in 2010 and headquartered in Waukesha, Wisconsin, manufactures UV-C microbial reduction systems for healthcare and commercial infection prevention. Its core technology is a patented triple-emitter UV-C architecture operating at approximately 254nm wavelength that applies inverse square law physics — deploying multiple light towers to shorten the distance from UV-C source to target surfaces, thereby reducing shadowing and cycle time without requiring repositioning. The product portfolio includes the FDA-authorized Helios+ UV-C System (Class II Medical Device), the first-generation Helios UV-C System (supporting up to five towers), PathTrac clinical decision support software for operating-room infection protocol monitoring, and SURFcare, a white-glove service program bundling dedicated account management, equipment maintenance, firmware updates, and cloud-based analytics reporting.

The company generates revenue through a combination of capital equipment sales (Helios+ and Helios systems, configurable with 1–3 or 1–5 emitters respectively) and recurring service revenue from the SURFcare program and PathTrac software subscriptions. Go-to-market combines direct enterprise field sales (with "Book a Demo" CTAs and virtual demos) targeting acute care hospitals, non-acute care facilities, government VA hospitals, dental offices, and non-healthcare commercial venues; channel partnerships with GPOs Premier and Vizient and credibility partners Leapfrog and KLAS; Foodbuy for commercial procurement; BreeWorld as an SDVOSB distributor for federal/DOD contracts; and a network of regional distributors covering 20+ countries across North America, Latin America, Europe, the Middle East, Africa, and Oceania. The company reports deployment across more than 1,000 facilities worldwide, holds ISO 13485:2016 MDSAP certification and BS 8626:2022 compliance, and operates with 11–50 employees under CEO Gunner Lyslo.

Surfacide firmographics

Firmographics
Name
Surfacide
Legal name
Surfacide, LLC.
Website
https://surfacide.com
Company type
Private
Founded year
2010
Operating status
Operating
Headcount range
11–50 employees
Short description
Surfacide designs and manufactures patented triple-emitter UV-C microbial reduction systems and infection-prevention software for healthcare facilities, government institutions, and commercial venues across 20+ countries.
Ownership category
akta.pro rank

Surfacide industry classification

Industry
Product category
Healthcare Disinfection Equipment
NAICS
Surgical and Medical Instrument Manufacturing (339112)
SIC
Surgical & Medical Instruments & Apparatus (3841), Industrial & Commercial Fans & Blowers & Air Purifing Equip (3564)
akta.pro industry
PRIMARYHLAHANAD
Disinfection & Surface Decontamination (Wipes, Sprays, Fogging, UV Robots)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Sterilization, Infection Prevention & Medical Disposables

Keywords

  • UV-C disinfection systems
  • Infection prevention technology
  • Healthcare disinfection equipment
  • Microbial reduction devices
  • UV-C germicidal technology

Where Surfacide is headquartered

Location

Headquarters

HQ city
Waukesha
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Surfacide business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Personnel, Technology or R&D, Marketing or Sales, Operations

Revenue model

  1. UV-C Hardware Systems: Sale of UV-C microbial reduction systems (Helios+, Helios) with multiple emitter configurations. Systems include robots/emitters, safety sensors, tablets, and cloud connectivity.
  2. SURFcare Service Program: Premium customer service program offering dedicated account manager, equipment maintenance, software/firmware updates, cloud database reporting, and equipment replacement. First year included with purchase.
  3. Advanced Analytics Dashboard: Customizable dashboard with widgets for data analysis, real-time data access, and scheduled reports. Part of SURFcare program.
  4. PathTrac Software: Clinical decision support software for operating room infection prevention protocols. Includes features for pathogen tracking, transmission mapping, and process optimization.

Pricing tiers

ModelBillingPrice
Unit PricingMulti-year contractHelios+ UV-C System with 3 emitters at competitive price point
SubscriptionAnnualSURFcare Premium Service Program

Go-to-market motion3 records

Distribution channels4 records

Marketing channels7 records

Surfacide product offering

Product offering

Core offering

Surfacide designs, engineers, and manufactures patented triple-emitter UV-C microbial reduction systems (Helios+ and Helios) that deliver whole-room disinfection of hard, non-critical medical device surfaces without repositioning. The systems use 253.7nm wavelength UV-C light to disrupt DNA/RNA of bacteria, some fungi, and lipid viruses, and are complemented by the PathTrac clinical decision support software and the SURFcare customer service program.

Product overview

Surfacide provides a portfolio of UV-C microbial reduction technology products and infection prevention software. The core offering is the Helios+ UV-C System (FDA-authorized Class II medical device) featuring a patented triple-emitter system for whole-room disinfection with no repositioning required. The earlier-generation Helios UV-C System offers similar technology with 1-5 tower configurability. PathTrac clinical decision support software complements the hardware by providing operating room infection monitoring through case pair modeling, transmission mapping, and bacterial strain identification. The SURFcare program delivers ongoing customer support, equipment management, and analytics services.

Differentiator

Problem solved

Functional benefit

Brands

  • Helios+ UV-C System: FDA-authorized Class II Medical Device UV-C system featuring three light-emitting towers for whole room microbial reduction.
  • PathTrac
  • Helios UV-C System
  • SURFcare

Products and services

  • Helios+ UV-C System FDA-authorized Class II medical device using a patented triple-emitter UV-C system operating at 253.7nm wavelength. Delivers whole-room microbial reduction on hard surfaces without repositioning through three simultaneously operating towers capable of 360-degree rotation, with configurable 1-3 tower deployments, safety sensors, and automatic cloud-based cycle data reporting. Designed for healthcare facilities including operating rooms, patient rooms, and clinical settings.
  • Helios UV-C System First-generation UV-C microbial reduction system with triple-emitter technology and configurable 1-5 tower configurations. Features 360-degree rotating light towers, motion sensors for safety, targeted area disinfection capabilities, and cloud-connected cycle data reporting. Sold to healthcare and commercial customers as Surfacide's original UV-C platform.
  • PathTrac Clinical decision support software for operating room infection prevention that identifies breakdowns in protocols through case pair modeling, transmission mapping, reservoir monitoring, and bacterial strain identification (MRSA, ESKAPE pathogens). Monitors the four pillars of infection control: hand hygiene, environmental cleaning, vascular care, and patient decolonization. Sold to healthcare facilities, particularly hospitals with operating room programs.
  • SURFcare Program White-glove concierge customer service program providing a dedicated account manager, equipment maintenance and replacement, software and firmware updates, and cloud database analytics with customizable reporting dashboards. First year included with every UV-C system purchase at no additional cost; subscription renewals thereafter. Targets Surfacide UV-C hardware customers.

Quantifiable outcome

  • Multiple emitter configurations eliminate need for repositioning, resulting in short cycle times and increased staff productivity
  • +2 more outcomes

Companies that use Surfacide

Customer profile

Named customers11 records

Segments5 records

Ideal customer profiles4 records

Surfacide technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature8 records

Surfacide partnerships and signals

Strategic signal

Partnerships

16 partnerships are on record, tiered core, flagship and regional.

  • FoodbuycoreChannel Partner/ Reseller/ DistributorFoodbuy enhances Surfacide's market reach and assists in procurement processes. As a group purchasing partner, Foodbuy provides access to their member network for commercial customers seeking UV-C disinfection solutions.
  • BreeWorldcoreChannel Partner/ Reseller/ DistributorDesignated Service-Disable Veteran-Owned Small Business (SDVOSB) distributor with more than 30 years DOD and Federal experience in healthcare industry. Provides access to government and federal healthcare contracts.
  • Leapfrog GroupflagshipGTM or Marketing PartnerLeapfrog serves as the foremost voice for business leaders advancing excellence in healthcare by setting standards and publishing ratings of hospitals and ASCs on quality of care. Partnership validates Surfacide's positioning in healthcare infection prevention.
  • KLAS ResearchcoreGTM or Marketing PartnerData-driven company on a mission to improve healthcare by enabling provider and payer voices to be heard. KLAS research directly reflects voice of healthcare professionals, providing market validation.
  • Premier Inc.flagshipChannel Partner/ Reseller/ DistributorPremier connects Surfacide with acute, non-acute, and alternate care site member communities. Group purchasing organization providing access to thousands of healthcare facilities.
  • VizientflagshipChannel Partner/ Reseller/ DistributorVizient offers greater access of Surfacide UV-C to more healthcare facilities in the US. Leading healthcare performance improvement company providing group purchasing services.
  • Dovonixc GlobalregionalChannel Partner/ Reseller/ DistributorDistributor for Africa/Nigeria region. Contact: +234 708 249 6134, info@dovonixcglobal.com
  • Wilhelm Integrated SolutionsregionalChannel Partner/ Reseller/ DistributorDistributor for Australia/New Zealand region. Contact: +61 2 8459 7588, sales@wilhelm.com.au
  • Farid ShehadehregionalChannel Partner/ Reseller/ DistributorVice President of Sales for Central & South America region. Contact: +305-458-4971
  • AlkamedicaregionalChannel Partner/ Reseller/ DistributorDistributor for Colombia/Costa Rica. CEO: Dra. Adiela Maria Cortes Cortes. Contact: +57-316-522-4029, acortes@alkamedica.com, www.alkamedica.com
  • Surfacide MexicoregionalChannel Partner/ Reseller/ DistributorDistributor for Mexico. Contact: Ian Rios, ventas@surfacidemexico.com, www.surfacidemexico.com
  • UV Technick, AGregionalChannel Partner/ Reseller/ DistributorDistributor for Switzerland. Contact: Rene Meyer, +41 56 664 16 01, r.meyer@uvc-technik.ch, www.uvc-technik.ch
  • Surfacide UKregionalChannel Partner/ Reseller/ DistributorDistributor for United Kingdom. UK Projects Manager: Jacob Veenhuis. Contact: jacobv@surfacidemfg.com
  • Dr. Sultan Alkhereiji / AlrowadregionalChannel Partner/ Reseller/ DistributorDistributor for Kingdom of Saudi Arabia. Address: WAHA DISTRICT, UTHMAN IBN AFFAN Rd. Contact: sultan@alrowad-ksa.com, Phone: +966 535631313, Office: +966 11 400 5640
  • Surfacide Medikal Teknolojileri LimitedregionalChannel Partner/ Reseller/ DistributorDistributor for Turkey. Global Business Consultant: Kasim Okcu. Contact: 90-505-502-3411
  • International Ultraviolet Association (IUVA)coreStrategic or Co-development PartnerIndustry association membership demonstrating commitment to UV technology standards and advancement. Part of industry ecosystem for infection prevention.

Scale indicators7 records

Recent moves6 records

Expansion highlights6 records

Surfacide competitors and assessment

Company assessment

Direct peers

  • Xenex Disinfection Services: Xenex sells the LightStrike pulsed-xenon UV robot for whole-room microbial reduction in hospitals, directly competing with Surfacide's Helios/Helios+ on the same no-repositioning room disinfection use case and selling into the same acute-care infection prevention buyer.
  • Tru-D SmartUVC: Tru-D markets a UV-C disinfection robot for healthcare terminal cleaning and HAI reduction, targeting the same hospital EVS and infection prevention decision makers as Surfacide and competing on dose delivery and single-cycle efficacy claims.
  • American Ultraviolet: American Ultraviolet manufactures UV germicidal fixtures and mobile UV-C disinfection units used in healthcare and commercial settings, making it a long-standing peer in the UV-C room disinfection category where Surfacide competes.

Broad incumbents

  • Clorox Healthcare: Clorox Healthcare is a major manufacturer of manual disinfectants, wipes, and surface cleaning chemistries used in hospitals, sitting alongside (and sometimes against) UV-C adjuncts like Surfacide's Helios+ in healthcare facility disinfection protocols.
  • PDI Healthcare: PDI Healthcare supplies disinfectants, wipes, and infection prevention products to acute and non-acute care settings, making it a broad incumbent whose portfolio complements or competes with Surfacide's UV-C hardware for the same hospital cleaning budget.
  • 3M Health Care: 3M's Health Care division spans surgical, infection prevention, and patient monitoring products and addresses the same hospital disinfection and environment-of-care spend as Surfacide, though as part of a much broader medtech portfolio.
  • Ecolab: Ecolab is a global leader in water, hygiene, and infection prevention solutions, serving hospitals and hospitality with cleaning chemistries and increasingly digital compliance programs that overlap with Surfacide's healthcare and commercial UV disinfection footprint.
  • Halma plc: Halma is a diversified group of safety and health technology companies with subsidiaries in UV-C disinfection and infection prevention, making it a broad incumbent in the healthcare and life-safety sensing and disinfection space where Surfacide operates.

Emerging players

  • AquiSense Technologies: AquiSense designs UV-C LED disinfection modules primarily for water and air treatment. It is an emerging player whose UV-C core technology overlaps with Surfacide's, though its focus is on point-of-use water/air systems rather than whole-room healthcare disinfection.
  • UV Smart: UV Smart offers UV-C disinfection devices for medical instruments and surfaces in clinical settings, an emerging player whose UV-C healthcare disinfection focus creates partial overlap with Surfacide's surface and equipment decontamination offering.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Surfacide social profiles

Digital presence

Surfacide compliance and trust

Trust signal

Compliance3 records

Surfacide financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Surfacide leadership team

Management profile

Number of profiles

Profiles2 records

Surfacide funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Surfacide M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Surfacide

What does Surfacide do?

Surfacide designs, engineers, and manufactures patented triple-emitter UV-C microbial reduction systems (Helios+ and Helios) that deliver whole-room disinfection of hard, non-critical medical device surfaces without repositioning. The systems use 253.7nm wavelength UV-C light to disrupt DNA/RNA of bacteria, some fungi, and lipid viruses, and are complemented by the PathTrac clinical decision support software and the SURFcare customer service program.

Is Surfacide a public or private company?

Surfacide is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Surfacide founded?

Surfacide was founded in 2010. It employs 11 to 50 people.

Where is Surfacide based?

Surfacide is headquartered in Waukesha, United States, in the North America region.

How does Surfacide make money?

Four revenue lines are on record. UV-C Hardware Systems are the primary driver. The others are SURFcare Service Program, advanced Analytics Dashboard and pathTrac Software.

Who are Surfacide's main competitors?

Direct peers on record are Xenex Disinfection Services, Tru-D SmartUVC and American Ultraviolet. Broad incumbents are Clorox Healthcare, PDI Healthcare, 3M Health Care, Ecolab and Halma plc. Emerging players are AquiSense Technologies and UV Smart.

Does Surfacide have an API?

No public API is recorded for Surfacide.

What industry is Surfacide in?

Surfacide's product category is Healthcare Disinfection Equipment. Its primary akta.pro industry code is HLAHANAD, Disinfection & Surface Decontamination (Wipes, Sprays, Fogging, UV Robots). Its NAICS code is 339112 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
GlobeNewswireSt. Bernard Hospital Accepts In-Kind Donation of Surfacide’s State-of-the-Art UV-C Disinfection TechnologySurfacide donated its Helios UV-C disinfection system, valued at $100,000, to St. Bernard Hospital in Chicago. The equipment will be deployed across key units, including the emergency department and ICU. The donation supports the hospital's Leapfrog patient safety rating improvement from an 'F' to an 'A' over three years.PR NewswireSurfacide® Launches SURFrx™ UV-C Disinfection Program Specifically For Pharmacy Sterile Compounding RoomsSurfacide, a UV-C disinfection technology company, has launched SURFrx, a new subscription-based UV-C disinfection program specifically designed for pharmacy sterile compounding rooms. The program addresses upcoming regulatory changes to USP <797> and <800> standards taking effect in November 2023, offering pharmacies an affordable monthly solution to achieve compliance with stricter environmental disinfection requirements. The Helios system uses a trio of UV-C light-emitting robotic units to achieve up to a 6-log reduction against common surface and airborne organisms in clean room environments.PR NewswireSurfacide® Announces the Launch of GLŌ™ PX ProgramSurfacide, a UV-C light technology company based in Waukesha, Wisconsin, announced the launch of its GLŌ PX Program, a subscription-based patient experience service for hospitals designed to improve HCAHPS scores and patient loyalty.PR NewswireSurfacide® UV-C Technology Featured in New Press Ganey / Compass One Healthcare Study For Improving Disinfection Efficacy and Patient Satisfaction ScoresPress Ganey and Compass One Healthcare released a whitepaper featuring Surfacide UV-C light technology as an evidence-based solution for improving hospital disinfection and patient satisfaction. A proof-of-concept study conducted at four hospitals using Surfacide's UV-C light robots resulted in quarterly patient satisfaction scores around cleanliness increasing between 5.5 and 17.5 points. Surfacide Founder and CEO Gunner Lyslo stated the company is proud to be profiled by these industry leaders as part of their strategies for hospitals to maintain high satisfaction scores.BizTimesSurfacide lands $45 million ECAT contractSurfacide signed a $45 million five-year ECAT contract with the Defense Logistics Agency to provide UV-C disinfection equipment to VA and DoD facilities. The system kills 99.99% of viruses and microorganisms on hard surfaces and in air. The contract expands access to 15 VA medical centers and over 500 health care facilities worldwide.PR NewswireSurfacide®, The Global Leader in UV Light Technology, Accelerate Their Procurement by VA Hospitals and Clinics with $45 Million ECAT ContractSurfacide, a Wisconsin-based UV disinfection technology company, has been awarded a $45 million ECAT (Electronic Catalog) contract over five years through the Defense Logistics Agency, enabling VA hospitals and clinics nationwide to procure its Helios System of UV-C light disinfection robots. The company is partnering with Fidelis Sustainability Distribution, a service-disabled veteran-owned distributor, to provide government customers access to the technology, which is already installed in 15 VA medical centers and over 500 healthcare facilities worldwide. Founded in 2010, Surfacide claims its triple-emitter Helios system can kill 99.99% of viruses and microorganisms on surfaces and in the air, including coronavirus and SARS-CoV-2.PR NewswireSurfacide Debuts Eos™ -- An Easy-To-Use UV Disinfection Device for Everyday Spaces and PlacesSurfacide announced Eos, a portable hospital-grade UV-C disinfection device for everyday spaces like schools and gyms. Priced under $20K, it offers floor-to-ceiling 360-degree disinfection and is available in early 2022. The device debuted at the ISSA Show North America in Las Vegas.PR NewswirePeer-Reviewed Study Confirms Surfacide® UV-C Extremely Effective in Killing SARS-CoV-2 On Surfaces and Air in EnvironmentsA peer-reviewed study published in the Journal of Clinical Anesthesia found Surfacide's Helios UV-C System to be nearly 95% effective in preventing SARS-CoV-2 in operating room environments, marking the first clinical evaluation of UV-C technology in actual surgical settings as opposed to controlled lab conditions. Testing of 473 intraoperative reservoir samples across 13 anesthesia work areas showed nearly a 2-fold reduction in SARS-CoV-2 detection compared to traditional surface disinfection cleaning procedures. Surfacide Founder and CEO Gunner Lyslo stated the findings validate the technology as a critical infection control measure, noting its ability to inactivate both aerosolized pathogens and surface contaminants.PR NewswireSurfacide UV Robots Are Fighting COVID-19 in Top Pediatric Hospitals Across the US and InternationallySurfacide, a UV disinfection company founded in 2010, has deployed its Helios System UV-C robots in more than a dozen leading pediatric hospitals across the United States and in the United Kingdom to help protect patients and healthcare workers from COVID-19. According to Royal Manchester Children's Hospital, Surfacide's UV-C technology achieved an 86% decrease in bacteria contaminant counts compared to 63% with traditional cleaning methods, while also delivering significant cost savings by reducing reliance on fogging equipment. The company, which holds the only patented triple emitter UV-C system and serves over 500 hospitals and institutions globally, is headquartered in Waukesha, Wisconsin.PR NewswireVizient Awards Contract to Surfacide for UV-C Solution That Can Help Hospitals Combat COVID-19Surfacide, a Waukesha-based UV-C decontamination technology company, has been awarded a contract with Vizient, the largest member-driven healthcare performance improvement company in the United States, for its multiple emitter UV-C solution effective July 1, 2020. The agreement provides Vizient's members—which include over half of US healthcare organizations ranging from integrated delivery networks to community hospitals—greater access to Surfacide's UV-C decontamination technology, which demonstrated efficacy against MERS Coronavirus in University of Iowa research data. Industry observers note the technology represents a long-term infection prevention solution as healthcare facilities continue battling COVID-19 and address heightened awareness around preventing hospital-acquired infections.